A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and the Drug-Drug Interaction Potential of Oral ACHN-383 and ACHN-789 in Healthy Subjects and to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ACHN-383 and ACHN-789 in Otherwise Healthy Subjects With Renal Impairment
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2017
At a glance
- Drugs C-Scape (Primary)
- Indications Urinary tract infections
- Focus Adverse reactions
- Sponsors Achaogen
- 03 Aug 2017 According to an Achaogen media release, first patient is dosed in this study.
- 26 May 2017 New source identified and integrated (NCT03163550).
- 20 May 2017 Status changed from planning to recruiting.